Product Name | MF | CAS | Details |
---|
BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
Eleven-Nineteen-Leukemia Protein IN-2 | 2894121-78-7 | Details |
Metallo-β-lactamase-IN-9 | 1802363-75-2 | Details |
(-)-15-Deoxyspergualin | 89149-10-0 | Details |
(R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
ML-077 | C17H16N4OS2 | 1135304-61-8 | Details |
CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
VU0621623 | C20H21F2N5O3S | 1115899-15-4 | Details |
N 0840 | C11H15N5 | 109292-91-3 | Details |
P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
Carbonic anhydrase inhibitor 12 | 2883451-38-3 | Details |
Eleven-Nineteen-Leukemia Protein IN-3 | 2894121-83-4 | Details |
Tubulin polymerization-IN-40 | 2921670-94-0 | Details |
S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
PI3K/mTOR Inhibitor-12 | 2891692-83-2 | Details |
α-Synuclein inhibitor 8 | 2883627-64-1 | Details |
3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
Antiproliferative agent-17 | 2882206-08-6 | Details |
CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
Eleven-Nineteen-Leukemia Protein IN-1 | 2894121-68-5 | Details |
MRS2768 tetrasodium salt | 2567869-47-8 | Details |
Mtb-cyt-bd oxidase-IN-6 | 1246461-10-8 | Details |
SARS-CoV-2 3CLpro-IN-5 | 2913186-57-7 | Details |
ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
KRAS G12C inhibitor 32 | 2756739-00-9 | Details |
COR167 | C28H38N2O2 | 1048038-90-9 | Details |
673-A | C15H13NO | 109437-62-9 | Details |
Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
(D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
(+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
(S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
ATM-3507 trihydrochloride | C37H47ClFN5O2 | 2438679-30-0 | Details |
Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
CBB1007 hydrochloride | C27H34N8O4.5ClH | 2070014-96-7 | Details |
BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
Topoisomerase IV inhibitor 1 | 2883403-42-5 | Details |
Enpp/Carbonic?anhydrase-IN-2 | 2883495-39-2 | Details |
Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
Product Total: Product Page: | ||||
17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 |